 HOUSTON, Aug. 24, 2022 GLOBE NEWSWIRE -- Alaunos Therapeutics, Inc. Alaunos or the Company Nasdaq: TCRT, a clinical-stage oncology-focused cell therapy company, today announced that it has been accepted to present a proffered talk at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference CICON being held in New York, NY from September 28 October 1, 2022. 